Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 282, Issue 1, 2005, Pages 24-37

  Zagon, Ian S ^a   Ruth, Torre B ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Immunoelectron microscopy; Importin; Karyopherin; Nuclear import; Nuclear localization signal; Nuclear receptor; Nucleocytoplasmic; Opioid

Indexed keywords

GROWTH FACTOR RECEPTOR; KARYOPHERIN BETA; METENKEPHALIN; NALTREXONE; OPIOID GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HETEROCHROMATIN; IMMUNOELECTRON MICROSCOPY; KERATINOCYTE; LASER MICROSCOPY; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TONGUE;

ANIMALS; BETA KARYOPHERINS; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; ENKEPHALIN, METHIONINE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; KERATINOCYTES; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEAR LOCALIZATION SIGNALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; TONGUE;

EID: 11344284667     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.20161     Document Type: Article

References (28)

1. Bendayan M. 1982. Double immunocytochemistry labeling applying the protein A-gold technique. J Histochem Cytochem 30:81-85.
2. Bendayan M, Nanci A, Kan FWK. 1987. Effect of tissue processing on colloidal gold cytochemistry. J Histochem Cytochem 35:983-996.
3. Bendayan M. 2000. A review of the potential and versatility of colloidal gold cytochemical labeling for molecular morphology. Biotech Histochem 75:203-242.
4. Berryman MA, Rodewald RD. 1990. An enhanced method for post-embedding immunocytochemical staining which preserves cell membranes, J Histochem Cytochem 38:159-170.
5. Cameron IL. 1966. Cell proliferation, migration, and specialization in the epithelium of the mouse tongue. Anat Rec 184:265-274.
6. Gasiorowski JZ, Dean DA. 2003. Mechanisms of nuclear transport and interventions. Adv Drug Deliver Rev 55:703-716.
7. Gorlich D, Kutay U. 1999. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Devel Biol 15:607-660.
8. Hess GD, McLaughlin PJ, Zagon IS. 2003. Naltrexone trafficking in COS-7 cells. FASEB J 17:A1216.
9. Hume WJ, Potten CS. 1983. Proliferative units in stratified squamous epithelium. Clin Exp Dermatol 8:95-106.
10. 5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 107:335-339.
11. McLaughlin PJ, Levin RJ, Zagon IS. 1999. Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int J Oncol 14:991-998.
12. McLaughlin PJ, Levin RJ, Zagon IS. 2003a. Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice. Cancer Lett 199:209-217.
13. McLaughlin PJ, Stack BC, Levin RJ, Fedok F, Zagon IS. 2003b. Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck. Cancer 97:1701-1710.
14. Mount SL, Taatjes DJ. 1994. Neuroendocrine carcinoma of the skin (Merkel cell carcinoma): an immunoelectron-microscopic case study. Amer J Dermatopathol 16:60-65.
15. Noda M, Furutani Y, Takahashi H, Toosata M, Hirose T, Inayama S, Nakanishi S, Numa S. 1982. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature 295:202-206.
16. Robbins J, Dilworth SM, Laskey RA, Dingwall C. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64:615-623.
17. Scala C, Cenacchi C, Ferrari C, Pasquinelli G, Preda P, Manara GC. 1992. A new acrylic resin formulation: a useful tool for histological, ultrastructural, and immunocytochemical investigations. J Histochem Cytochem 40:1799-1804.
18. Varndell IM, Polak JM. 1984. Immunolabelling for electron microscopy. New York: Elsevier. p 155-177.
19. Varndell IM, Sikri KL, Hennessy RJ, Goodman RH, Benoit R, Diani AR, Polak JM. 1986. Somatostatin-containing D cells exhibit immunoreactivity for rat somatostatin cryptic peptide in six mammalian species. Cell Tissue Res 246:197-204.
20. Xu L, Massague J. 2004. Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 5:1-11.
21. Zagon IS, McLaughlin PJ. 1984. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth. Life Sci 35:2057-2064.
22. Zagon IS, McLaughlin PJ. 1993. Production and characterization of polyclonal and monoclonal antibodies to zeta (ζ) opioid receptor. Brain Res 630:295-302.
23. Zagon IS, Wu Y, McLaughlin PJ. 1994a. Opioid antagonist modulation of DNA synthesis in mouse tongue epithelium is circadian dependent. Pharmacol Biochem Behav 48:709-714.
24. Zagon IS, Wu Y, McLaughlin PJ. 1994b. Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am J Physiol 267:R645-R652.
25. 5]-enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea. Brain Res 671:105-111.
26. 5]-enkephalin. Brain Res 849:147-154.
27. Zagon IS, Verderame MF, McLaughlin PJ. 2002. The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 38:351-376.
28. Zagon IS, Ruth TB, Leure-duPree AE, Sassani JW, McLaughlin PJ. 2003. Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. Brain Res 967:37-47.